Hepatic lipids of guinea pigs treated with 0.0, 0.8, 3.7, and 13.4 mg/kg/day ASBT inhibitor
| Treatment | Hepatic Lipid | |||
|---|---|---|---|---|
| TC | FC | EC | TG | |
| mg/kg/day | mg/g | |||
| ASBT inhibitor | ||||
| 0.0 (control) | 3.2 ± 1.0 | 2.3 ± 0.7 | 0.91 ± 0.55 | 32.9 ± 14.7 |
| 0.8 | 2.9 ± 1.4 | 2.4 ± 1.1 | 0.52 ± 0.474-160 | 24.5 ± 7.1 |
| 3.7 | 3.2 ± 1.0 | 2.8 ± 0.9 | 0.40 ± 0.324-160 | 39.8 ± 13.5 |
| 13.4 | 2.2 ± 0.8 | 1.9 ± 0.7 | 0.27 ± 0.224-160 | 26.3 ± 9.5 |
Data are presented as means ± SD; n = 10/group. Values in the same column with different superscripts are significantly different as determined by one-way ANOVA and the Newman-Keuls as post hoc test.
TC, total cholesterol; FC, free cholesterol; EC, esterified cholesterol.
↵4-160 P < 0.01.